Prosecution Insights
Last updated: April 19, 2026

Protagonist Therapeutics Inc.

6 pending office actions

Portfolio Summary

6
Total Pending OAs
1
Final Rejections
5
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18285203 CONJUGATED HEPCIDIN MIMETICS COFFA, SERGIO 1658 Non-Final OA Sep 29, 2023
18139254 METHODS FOR TREATING INFLAMMATORY BOWEL DISEASES WITH a4B7 INTEGRIN ANTAGONISTS OLISS, BRENDAN PATRICK NOON 1658 Non-Final OA Apr 25, 2023
18018482 CONJUGATED HEPCIDIN MIMETICS KOMATSU, LI N 1658 Non-Final OA Jan 27, 2023
18018481 CONJUGATED HEPCIDIN MIMETICS KONOPELSKI SNAVEL, SARA ELIZABETH 1658 Non-Final OA Jan 27, 2023
18097077 PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES NIEBAUER, RONALD T 1658 Final Rejection Jan 13, 2023
17788179 Methods for Treating Inflammatory Bowel Diseases with alpha4beta7 Integrin Antagonists BEANE, RANDALL L 1654 Non-Final OA Jun 22, 2022

Managing Protagonist Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month